Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
ANVS
Annovis Bio, Inc.
Buntanetap is described as an orally administered small molecule therapeutic, aligning with the 'Oral Small Molecule Therapeutics' investable theme.
|
$95.87M |
$4.94
+2.49%
|
|
NCSM
NCS Multistage Holdings, Inc.
Tracer diagnostics capabilities and studies are a key service offering for reservoir and well performance analysis.
|
$95.13M |
$37.62
+2.23%
|
|
RPTX
Repare Therapeutics Inc.
Core company focus is oncology therapeutics with a synthetic lethality approach (Biotech - Oncology).
|
$94.94M |
$2.20
+3.77%
|
|
TVGN
Tevogen Bio Holdings Inc.
ExacTcell off-the-shelf T cell therapies and the TVGN 489 program position Tevogen as a cell therapy biotech focused on oncology and infectious disease.
|
$94.62M |
$0.49
+10.94%
|
|
PRLD
Prelude Therapeutics Incorporated
Prelude is a clinical-stage biotech focused on oncology, with an advanced pipeline targeting SMARCA2/SMARCA4 and related cancer pathways.
|
$94.52M |
$1.67
+5.03%
|
|
ADAG
Adagene Inc.
Core focus on monoclonal antibody therapeutics (ADG126 and related SAFEbody-based antibodies).
|
$93.85M |
$2.12
+6.53%
|
|
MGNX
MacroGenics, Inc.
Company develops bispecific antibody therapies via its DART platform, including lorigerlimab.
|
$93.54M |
$1.48
+1.72%
|
|
ELDN
Eledon Pharmaceuticals, Inc.
Tegoprubart is an IgG1 monoclonal antibody therapeutic targeting CD40L.
|
$92.82M |
$1.54
-7.78%
|
|
FONR
FONAR Corporation
Core product offering is the Upright MRI hardware, a specialized medical imaging platform.
|
$92.66M |
$14.10
-0.70%
|
|
CRVO
CervoMed Inc.
Neflamapimod is an orally administered, small-molecule therapeutic, aligning with the 'Oral Small Molecule Therapeutics' category.
|
$91.97M |
$9.98
+3.69%
|
|
STIM
Neuronetics, Inc.
NeuroStar Advanced Therapy System is a non-invasive neuromodulation device; the direct product of the company.
|
$91.91M |
$1.39
+1.09%
|
|
EDAP
Edap Tms S.a.
Focal One is a robotic surgical energy delivery device used for focal therapy of urological cancers.
|
$90.29M |
$2.43
+0.83%
|
|
CSBR
Champions Oncology, Inc.
Company provides outsourced drug development and preclinical/clinical research services to biopharma (CRO-style).
|
$89.55M |
$6.50
|
|
ARTV
Artiva Biotherapeutics, Inc.
AlloNK AB-101 is an allogeneic NK cell therapy platform, constituting Artiva's core product line.
|
$87.44M |
$3.59
+6.53%
|
|
ADVM
Adverum Biotechnologies, Inc.
Lead program Ixo-vec is a gene therapy for an ocular indication, placing Adverum in the Biotech - Gene Therapy category.
|
$87.29M |
$4.17
+1.83%
|
|
NSPR
InspireMD, Inc.
InspireMD's core products are vascular/interventional endovascular devices (carotid stent systems with embolic protection).
|
$87.20M |
$2.07
+3.50%
|
|
VTVT
vTv Therapeutics Inc.
Cadisegliatin is an oral, small-molecule therapeutic developed by the company for Type 1 Diabetes, directly matching the 'Oral Small Molecule Therapeutics' category.
|
$86.25M |
$27.40
-1.72%
|
|
LFVN
LifeVantage Corporation
LoveBiome's microbiome/gut-health focus expands into digestive-health supplement opportunities.
|
$85.79M |
$6.75
-0.30%
|
|
NIKA
Nika Pharmaceuticals Inc.
ITV-1 HIV therapeutic concept and related immunomodulatory platform sit within Biotech - Immunology Therapeutics.
|
$85.13M |
$0.30
|
|
BYSI
BeyondSpring Inc.
BeyondSpring develops oncology therapeutics (Plinabulin) with a novel SIMBA mechanism, directly addressing cancer and CIN.
|
$84.29M |
$2.11
+6.57%
|
|
GOCO
GoHealth, Inc.
GoHealth's core offering is health insurance enrollment and management for Medicare plans.
|
$83.83M |
$2.93
|
|
HIT
Health In Tech, Inc.
HIT operates in health insurance by enabling quotes, plans, and related services through its platform.
|
$83.46M |
$1.48
+2.78%
|
|
FBIO
Fortress Biotech, Inc.
Fortress Biotech directly encompasses oncology-focused biotech through its portfolio (e.g., Mustang Bio) and related assets, aligning with Biotech - Oncology.
|
$82.12M |
$2.77
+2.79%
|
|
VXRT
Vaxart, Inc.
VXRT directly develops and advances vaccines (norovirus, COVID-19, avian influenza) using its VAAST oral vaccine platform.
|
$81.83M |
$0.36
|
|
HYPR
Hyperfine, Inc.
Hyperfine's Swoop portable MRI is a medical imaging device, directly fitting the Medical Imaging category.
|
$81.72M |
$1.03
-4.17%
|
|
XTNT
Xtant Medical Holdings, Inc.
Company designs, manufactures, and sells orthopedic surgical implants (e.g., spinal implants) and orthobiologic products.
|
$81.41M |
$0.65
+2.40%
|
|
INVE
Identiv, Inc.
Healthcare-focused applications (biometric sensing, device authentication) intersect with medical device/biometrics themes.
|
$81.13M |
$3.47
+0.58%
|
|
TIL
Instil Bio, Inc.
Instil Bio's lead candidate AXN-2510/IMM2510 is a bispecific antibody, placing the company squarely in the Bispecific Antibodies investable theme.
|
$80.87M |
$12.01
+4.62%
|
|
VANI
Vivani Medical, Inc.
Vivani's NanoPortal is a proprietary drug-implant platform enabling ultra long-acting, localized drug delivery.
|
$80.57M |
$1.36
+3.41%
|
|
ONCY
Oncolytics Biotech Inc.
Pelareorep is an oncolytic virus immunotherapy developed by Oncolytics Biotech, placing the company in Biotech - Oncology.
|
$80.16M |
$1.04
+0.97%
|
|
LHSW
Lianhe Sowell International Group Ltd Ordinary Shares
Exploration into medical applications via machine vision implies Medical Devices & Biometrics relevance.
|
$79.30M |
$1.43
-8.33%
|
|
OM
Outset Medical, Inc.
Outset's Tablo Hemodialysis System is a medical device; tag as Medical Devices & Biometrics.
|
$78.88M |
$4.43
-0.89%
|
|
IGMS
IGM Biosciences, Inc.
IGMS's IgM antibody platform represents an antibody discovery platform used to develop novel therapeutics.
|
$76.35M |
$1.27
|
Showing page 26 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
